Related Experiment Video
Updated: Aug 17, 2026

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
Published on: April 19, 2024
Understanding the enzymology of fibrinolysis and improving thrombolytic therapy
Colin Longstaff1, Craig Thelwell
1Division of Haematology, National Institute for Biological Standards and Control, South Mimms, Herts, EN6 3QG, UK. clongstaff@nibsc.ac.uk
Abstract:
Cardiovascular disease is responsible for 17 million deaths per year but acute myocardial infarction and stroke can be treated with thrombolytics ("clot busters"), which are plasminogen activators. However, despite many years of study and huge investment from the pharmaceutical industry, clinical trials of new drugs have often been disappointing. Part of the problem may be our incomplete understanding of the regulation of plasminogen activation in vivo. We have developed precise in vitro methods and with the application of computer simulations, we hope to improve our understanding of plasminogen activation to facilitate improvements in thrombolytic therapy.
Insights
Understanding clot buster regulation is key to improving treatments for heart attack and stroke. This study uses in vitro methods and computer simulations to better understand plasminogen activation, aiming for enhanced thrombolytic therapy.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Computational Biology
Background:
- Cardiovascular diseases cause 17 million deaths annually.
- Thrombolytic drugs, or "clot busters," are plasminogen activators used to treat acute myocardial infarction and stroke.
- Despite significant investment, clinical trials for new thrombolytic drugs have yielded disappointing results, suggesting incomplete understanding of plasminogen activation regulation in vivo.
Purpose of the Study:
- To improve the understanding of plasminogen activation regulation in vivo.
- To facilitate advancements in thrombolytic therapy for cardiovascular diseases.
Main Methods:
- Development of precise in vitro methods for studying plasminogen activation.
- Application of computer simulations to analyze and model plasminogen activation pathways.
Main Results:
- Precise in vitro methods have been established.
- Computer simulations are being employed to enhance understanding.
Conclusions:
- Improved understanding of plasminogen activation regulation is crucial for developing more effective thrombolytic therapies.
- This research aims to bridge the gap between in vitro findings and in vivo mechanisms to improve treatment outcomes for acute myocardial infarction and stroke.
Related Concept Videos
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

